219.25
+0.18
+(0.08%)
At close: April 17 at 6:54:00 PM GMT+1
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 12 | 12 | 14 | 14 |
Avg. Estimate | 559.87M | 553.72M | 2.22B | 2.31B |
Low Estimate | 522M | 523M | 2.12B | 2.19B |
High Estimate | 576.2M | 587.86M | 2.29B | 2.41B |
Year Ago Sales | 502.1M | 513.8M | 2.07B | 2.22B |
Sales Growth (year/est) | 11.51% | 7.77% | 7.01% | 4.29% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
0HQN.L | -- | -- | -- | -- |
S&P 500 | 6.92% | 4.87% | 8.58% | 14.16% |
Upgrades & Downgrades
Maintains | Oppenheimer: Outperform to Outperform | 4/11/2025 |
Downgrade | B of A Securities: Buy to Neutral | 4/10/2025 |
Maintains | Piper Sandler: Overweight to Overweight | 4/8/2025 |
Maintains | Barclays: Equal-Weight to Equal-Weight | 4/7/2025 |
Maintains | B of A Securities: Buy to Buy | 2/10/2025 |
Maintains | Barclays: Equal-Weight to Equal-Weight | 2/10/2025 |